This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
PG vs. CHD: Which Consumer Goods Stock Offers the Best Long-Term Value?
by Mahak Lohia
Procter & Gamble's scale and digital edge go head-to-head with Church & Dwight's focused brand play in the fight for long-term value.
Newell's Smart Productivity Moves Likely to Offset Cost Pressures
by Zacks Equity Research
NWL boosts profitability through productivity gains, automation, cost control and strategic supply-chain improvements.
Procter & Gamble (PG) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
The latest trading day saw Procter & Gamble (PG) settling at $161.03, representing a +1.23% change from its previous close.
Can Procter & Gamble's Pricing Power Keep Earnings Buoyant in 2025?
by Zacks Equity Research
PG leverages value-based pricing and innovation to enhance consumer value, profits and market share.
Colgate Taps Productivity Plan, Enhances Profits, Protects Margins
by Zacks Equity Research
CL streamlines supply chain, modernizes manufacturing and cuts overhead to boost efficiency and execution.
Clorox's Innovation Strategy Elevates Everyday Essentials
by Zacks Equity Research
CLX leans on premium innovation and smart pricing to protect market share and margins amid shifting consumer demand.
Here is What to Know Beyond Why Procter & Gamble Company (The) (PG) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Are PG's Beauty and Health Units Driving the Next Leg of Growth?
by Zacks Equity Research
Procter & Gamble drives global well-being through product innovation and CSR across health, hygiene and cleaning.
CLX's Productivity Drive: Likely to Aid Margins & Offset High Costs?
by Zacks Equity Research
Clorox sharpens its productivity edge with digital tools, empowered teams and a leaner operating model for agile growth.
Procter & Gamble (PG) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
Procter & Gamble (PG) reached $160.28 at the closing of the latest trading day, reflecting a -1.78% change compared to its last close.
Is PG's Supply Chain Revamp a Game-Changer in Consumer Staples?
by Zacks Equity Research
Procter & Gamble's digital supply chain overhaul and AI-powered automation aim to blunt tariff shocks and boost resilience.
Procter & Gamble Slips Below 50-Day SMA: Time to Buy or Exit?
by Rajani Lohia
PG breaks below key technical levels as sales soften. A trimmed outlook raises questions about valuation support amid slowing growth.
PG's Productivity Drive: Enough to Offset FX and Cost Pressures?
by Zacks Equity Research
Procter & Gamble leans on productivity investments to offset inflation and currency swings, aiming to protect and grow margins.
Why Is Energizer (ENR) Up 2.6% Since Last Earnings Report?
by Zacks Equity Research
Energizer (ENR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Procter & Gamble (PG) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
The latest trading day saw Procter & Gamble (PG) settling at $165.95, representing a -0.54% change from its previous close.
Clorox (CLX) Down 3.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)?
by Zacks Equity Research
Sector ETF report for IYK
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Should You Invest in the Vanguard Consumer Staples ETF (VDC)?
by Zacks Equity Research
Sector ETF report for VDC
Top Beauty and Cosmetics Stocks That Could Be in Your Portfolio
by Ansuiya Mohta
Leading companies like COTY, ULTA and SBH are tapping tech, innovation and shifting trends to stay ahead in the fast-evolving beauty market.
Is P&G (PG) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), P&G (PG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Procter & Gamble Vs Unilever: Who Holds the Power in the FMCG Race?
by Rajani Lohia
PG and UL stand tall in the FMCG arena, with PG showcasing brand strength and pricing power, while UL leverages global reach and innovation to fuel momentum.
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Zacks Equity Research
Sector ETF report for FSTA
Procter & Gamble Stock Slips 5% in a Month: Buy the Dip or Stay Wary?
by Rajani Lohia
PG faces near-term headwinds related to the market issues in Greater China, geopolitical tensions and financial impacts of currency volatility.
Brokers Suggest Investing in P&G (PG): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?